Developer docs
API playgroundTry for free, no card

Search company profiles

BioCare

Full company profile

uuid0009dh1

Namestring
BioCare
Legal namestring
BioCare, Inc.
Websiteurl
biocare-us.com
Company typeenum
Private
Founded yearint
1981
Descriptiontext

BioCare, Inc. is a Tempe, Arizona-based specialty pharmaceutical distribution platform founded in 1981 (as a division of Blood Systems) and incorporated as a separate for-profit entity in 2017. The company operates a multi-brand portfolio centered on BioCareSD, which provides high-touch specialty drug distribution of life-saving therapies — including biologics, plasma-derived products, gene therapies, and rare-disease medications — to specialty pharmacies, infusion centers, hospitals, and other sites of care across the U.S. and Puerto Rico, supported by distribution centers in Tempe, AZ and Olive Branch, MS. BioCare extends its platform vertically through LogiCare3PL (third-party logistics including warehousing, cold-chain distribution, inventory management, order-to-cash, and DSCSA compliance), AllyGPO (a specialty group purchasing organization for independent oncology and retina practices operated in joint venture), CanyonCare Rx (specialty pharmacy services), and QRCare (quality and regulatory consultancy).

The underlying technology stack combines Salesforce CRM-based sales pipeline management, a TraceLink electronic portal for prescription drug pedigree compliance under DSCSA, and AeroSafe reusable cold-chain shipping containers — together supporting regulatory compliance, cold-chain integrity, and order-to-cash operations rather than any proprietary AI or advanced analytics layer. BioCare's revenue model is transaction-based for specialty distribution and managed-services-based for 3PL, with quote-based, non-publicly-disclosed pricing across both manufacturer and provider customer segments. BioCare holds NABP Drug Distributor Accreditation for both BioCareSD and LogiCare3PL, is backed by The Vistria Group (growth investment, November 2021), and has earned consecutive Inc. 5000 (2022-2023), Financial Times Americas' Fastest Growing Companies (2025), and GLOBEE Gold Award (2026) recognition.

Short descriptiontext

BioCare is a Tempe, Arizona-based specialty pharmaceutical distributor serving manufacturers, independent oncology and retina practices, infusion centers, and hospitals across the U.S. through BioCareSD distribution, LogiCare3PL logistics, AllyGPO group purchasing, and QRCare regulatory services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersTempe, Australia
HQ citystring
Tempe
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
specialty pharmaceutical distribution, cold chain logistics, third-party logistics, group purchasing organization, specialty drug distribution
Industry5 codes
PRIMARYCRAOAHAD
Specialty Pharmacy & Biologics Distribution
SECONDARYHLAIAJAH
Biologics & Biosimilars Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYHLAGAMAD
Specialty Pharma & Biologics Distribution (GDP-compliant)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Supply Chain, Logistics & Cold Chain for Life Sciences
SECONDARYHLAGAKAO
Third-Party/Outsourced Quality & Responsible Person Services (EU QP/RP, US Agent)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
NAICS code1 code
  • Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers42345
SIC code2 codes
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
  • Biological Products, (No Disgnostic Substances)2836
Product category
Specialty Pharmaceutical Distribution
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Specialty Pharmaceutical Distribution
TypeTransaction Fee
Description

BioCare generates revenue through specialty pharmaceutical distribution services, handling life-saving therapies for rare diseases. The company serves as exclusive or limited distributor for manufacturer partners, earning transaction-based fees for distribution services. Core business model spans over 40 years.

biocare-us.com
2Third-Party Logistics (3PL) Services
TypeManaged Services
Description

LogiCare3PL provides comprehensive third-party logistics including warehousing, cold chain distribution, inventory management, financial services, data analytics, licensing services, and regulatory compliance for specialty pharmaceutical manufacturers.

biocare-us.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Supply Chain, Personnel, Infrastructure, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

BioCare is a specialty pharmaceutical distribution company that distributes life-saving therapies for rare, orphan, and ultra-rare diseases through its BioCareSD division. It also offers third-party logistics (LogiCare3PL), including warehousing, cold chain distribution, inventory management, order-to-cash services, financial services, data analytics, licensing, and regulatory compliance (DSCSA) for specialty pharmaceutical manufacturers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Recognized as Inc. 5000 Fastest-Growing Private Companies in America for two consecutive years (2022-2023)
+2 more records
Product overview1 text field

BioCare is a specialty pharmaceutical distribution company with a multi-brand platform consisting of BioCareSD (specialty distribution), LogiCare3PL (third-party logistics), and AllyGPO (group purchasing organization), along with supporting services QRCare (regulatory consultancy), CanyonCare Rx, and BioCareSD e-Commerce. The company serves manufacturers, pharmacies, healthcare providers, and patients across specialty drugs, rare diseases, oncology, and retina therapeutic areas.

Product and service6 records
1BioCareSD Specialty Distribution
CategorySpecialty Pharmaceutical Distribution
Description

Specialty pharmaceutical distribution division providing warehousing, fulfillment, and distribution of life-saving therapies (oncology, retina, rare/ultra-rare disease, plasma-derived, gene therapies, biologics) to specialty pharmacies, infusion centers, hospitals, and other sites of care. For pharmaceutical manufacturers and healthcare providers.

2LogiCare3PL Third-Party Logistics
CategoryThird-Party Logistics (3PL)
Description

Third-party logistics division providing warehousing, cold chain distribution, inventory management, financial services, data analytics, licensing services, and DSCSA regulatory compliance expertise and infrastructure for specialty and rare disease manufacturers.

3AllyGPO Group Purchasing Organization
CategoryGroup Purchasing Organization
Description

Next-generation specialty group purchasing organization providing independent oncology and retina practices with purchasing power and optimized specialty drug distribution through strategic partnerships.

4QRCare Regulatory Consultancy
CategoryConsulting Services
Description

Quality and regulatory consultancy service providing strategic support for partners to develop and maintain quality and regulatory compliance programs in the pharmaceutical industry.

5CanyonCare Rx Specialty Pharmacy
CategorySpecialty Pharmacy
Description

Specialty pharmacy services division dispensing specialty medications to patients, particularly those with rare and complex diseases.

6BioCareSD e-Commerce Platform
CategoryE-Commerce Platform
Description

Online ordering platform for BioCareSD customers to place orders and manage accounts electronically.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership18 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-06-18
Description

OCSRI selected BioCareSD and AllyGPO as its primary specialty drug distributor and GPO partner.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-06-09
Description

Mission-aligned partnership with AllyGPO (next-generation specialty group purchasing organization) to transform specialty drug group purchasing and distribution for independent oncology and retina practices. Earned Gold Globee Award in 2026 for this partnership.

3Utah Cancer Specialists
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-05-27
Description

Partnership with AllyGPO and BioCareSD to optimize specialty drug purchasing, distribution and drug management.

biocare-us.com
Strategic tierStrategicTypeTechnology or IntegrationAnnounced on2026-05-19
Description

Strategic partnership with WeInfuse, a leading infusion management technology platform used by providers across more than 1,300 locations nationwide. The collaboration enables closer integration for infusion practice technology capabilities.

5Dothan Hematology & Oncology
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-04-27
Description

Selected AllyGPO and BioCareSD as primary specialty group purchasing and drug distributor partners.

biocare-us.com
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-03-06
Description

BioCare serves as a distribution partner for Kedrion's FDA-approved QIVIGY (intravenous immunoglobulin therapy). QIVIGY is Kedrion's first fully proprietary IVIG product, developed and manufactured through their integrated global network.

7CuraScript SD
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-03-06
Description

Distribution partner for Kedrion's QIVIGY product launch in the nationwide distribution network.

biospace.com
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-03-06
Description

Distribution partner for Kedrion's QIVIGY product launch in the nationwide distribution network.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-03-06
Description

Distribution partner for Kedrion's QIVIGY product launch in the nationwide distribution network.

10McKesson Plasma and Biologics
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-03-06
Description

Distribution partner for Kedrion's QIVIGY product launch in the nationwide distribution network.

biospace.com
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-03-06
Description

Group purchasing organization (GPO) relationship supporting Kedrion's QIVIGY distribution through the nationwide network.

12ChiRhoClin, Inc.
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-07-16
Description

LogiCare3PL serves as exclusive third-party logistics provider for ChiRhoStim (Human Secretin for injection), a product for pancreatic and gastrointestinal diagnostics.

biocare-us.com
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-04-28
Description

LogiCare3PL supported commercial launch of VYKAT XR (Soleno Therapeutics' FDA-approved therapy) for hyperphagia in Prader-Willi syndrome patients.

Strategic tierStrategicTypeTechnology or IntegrationAnnounced on2024-10-02
Description

Partnership to launch sustainable cold chain solutions using innovative reusable temperature-controlled shipping containers for specialty pharmaceutical products.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-08-19
Description

Limited distribution partnership for ALYGLO (immune globulin intravenous, human-stwk), a 10% immune globulin liquid product.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-04-14
Description

LogiCare3PL selected as distribution partner for Harrow's portfolio of ophthalmic disease management solutions, providing both non-title and 3PL title services.

Strategic tierStrategicTypeChannel Partner/ Reseller/ DistributorAnnounced on2023-07-28
Description

Launched specialty-only distributor-GPO alternative for community retina practices at the ASRS Annual Meeting, combining BioCareSD distribution with AllyRetina GPO services.

Strategic tierCoreTypeTechnology or Integration
Description

Partnership with TraceLink to provide electronic portal solution for prescription drug pedigree compliance under DSCSA (Drug Supply Chain Security Act), allowing customers to view and download transaction history.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Specialty biopharmaceutical distributor serving plasma products, vaccines, and specialty therapeutics through VeriCap and NuFACTOR subsidiaries. Highly comparable as an independent specialty-only distributor focused on plasma/biologics distribution with cold chain capabilities.

2CuraScript SD
TypeDirect peer
Description

Specialty pharmaceutical distributor focused on limited distribution for rare, orphan, and oncology therapies. Explicitly listed alongside BioCare as a distribution partner for Kedrion's QIVIGY launch, making it a direct competitor for the same manufacturer and provider accounts.

TypeEmerging player
Description

Global contract development and manufacturing organization with integrated specialty distribution and cold chain capabilities. Comparable as a competitor for specialty manufacturer 3PL mandates, though broader in scope including manufacturing services.

TypeBroad incumbent
Description

Specialty distribution business of Cardinal Health offering nuclear pharmacy, biopharma services, and provider solutions. Competes with BioCare for manufacturer distribution rights and community oncology/retina customers, with materially larger national scale.

TypeBroad incumbent
Description

Specialty pharmacy and distribution arm of UnitedHealth/Optum. Competes with BioCare's CanyonCare Rx and for limited distribution rights on behalf of manufacturers seeking payer-integrated specialty channels.

TypeDirect peer
Description

Specialty GPO and services platform serving community urology, oncology, and other independent specialty practices. Direct comparable to AllyGPO in providing GPO + distributor solutions for independent specialty practices.

TypeBroad incumbent
Description

Specialty pharmacy and distribution business with broad national reach. Competes for both distribution-to-pharmacy volumes and downstream specialty pharmacy fulfillment for the same oncology and rare-disease therapeutics BioCare distributes.

8Sharp Specialty (formerly BDI Pharma)
TypeDirect peer
Description

Specialty distributor of plasma derivatives, vaccines, and specialty injectables. Comparable as an independent specialty-only distributor competing for the same plasma-derived and rare-disease manufacturer partnerships.

TypeBroad incumbent
Description

Specialty and biologics distribution under ASD Healthcare and Specialty Provider Services. Cencora is explicitly a partner alongside BioCare on the QIVIGY launch, making it the most dominant competing specialty distributor for manufacturer mandates.

10McKesson Specialty Health (Ontada)
TypeBroad incumbent
Description

Specialty distribution and provider services arm of McKesson serving oncology practices and biologics manufacturers. Direct overlap with BioCare's oncology and retina segments; competes for the same limited distribution contracts and Prime Vendor Agreements.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries5 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BioCare

Specialty Pharmaceutical Distributionbiocare-us.com

BioCare is a Tempe, Arizona-based specialty pharmaceutical distributor serving manufacturers, independent oncology and retina practices, infusion centers, and hospitals across the U.S. through BioCareSD distribution, LogiCare3PL logistics, AllyGPO group purchasing, and QRCare regulatory services.

What BioCare does

BioCare, Inc. is a Tempe, Arizona-based specialty pharmaceutical distribution platform founded in 1981 (as a division of Blood Systems) and incorporated as a separate for-profit entity in 2017. The company operates a multi-brand portfolio centered on BioCareSD, which provides high-touch specialty drug distribution of life-saving therapies — including biologics, plasma-derived products, gene therapies, and rare-disease medications — to specialty pharmacies, infusion centers, hospitals, and other sites of care across the U.S. and Puerto Rico, supported by distribution centers in Tempe, AZ and Olive Branch, MS. BioCare extends its platform vertically through LogiCare3PL (third-party logistics including warehousing, cold-chain distribution, inventory management, order-to-cash, and DSCSA compliance), AllyGPO (a specialty group purchasing organization for independent oncology and retina practices operated in joint venture), CanyonCare Rx (specialty pharmacy services), and QRCare (quality and regulatory consultancy).

The underlying technology stack combines Salesforce CRM-based sales pipeline management, a TraceLink electronic portal for prescription drug pedigree compliance under DSCSA, and AeroSafe reusable cold-chain shipping containers — together supporting regulatory compliance, cold-chain integrity, and order-to-cash operations rather than any proprietary AI or advanced analytics layer. BioCare's revenue model is transaction-based for specialty distribution and managed-services-based for 3PL, with quote-based, non-publicly-disclosed pricing across both manufacturer and provider customer segments. BioCare holds NABP Drug Distributor Accreditation for both BioCareSD and LogiCare3PL, is backed by The Vistria Group (growth investment, November 2021), and has earned consecutive Inc. 5000 (2022-2023), Financial Times Americas' Fastest Growing Companies (2025), and GLOBEE Gold Award (2026) recognition.

BioCare firmographics

Firmographics
Name
BioCare
Legal name
BioCare, Inc.
Website
https://biocare-us.com
Company type
Private
Founded year
1981
Operating status
Operating
Headcount range
101–250 employees
Short description
BioCare is a Tempe, Arizona-based specialty pharmaceutical distributor serving manufacturers, independent oncology and retina practices, infusion centers, and hospitals across the U.S. through BioCareSD distribution, LogiCare3PL logistics, AllyGPO group purchasing, and QRCare regulatory services.
Ownership category
akta.pro rank

BioCare industry classification

Industry
Product category
Specialty Pharmaceutical Distribution
NAICS
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (42345)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYCRAOAHAD
Specialty Pharmacy & Biologics Distribution
SECONDARYHLAIAJAH
Biologics & Biosimilars Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYHLAGAMAD
Specialty Pharma & Biologics Distribution (GDP-compliant)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Supply Chain, Logistics & Cold Chain for Life Sciences
SECONDARYHLAGAKAO
Third-Party/Outsourced Quality & Responsible Person Services (EU QP/RP, US Agent)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

Keywords

  • Specialty pharmaceutical distribution
  • Cold chain logistics
  • Third-party logistics
  • Group purchasing organization
  • Specialty drug distribution

Where BioCare is headquartered

Location

Headquarters

HQ city
Tempe
HQ country
Australia
HQ region
Oceania

Offices2 records

Markets served

BioCare business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Operations, Supply Chain, Personnel, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Specialty Pharmaceutical Distribution: BioCare generates revenue through specialty pharmaceutical distribution services, handling life-saving therapies for rare diseases. The company serves as exclusive or limited distributor for manufacturer partners, earning transaction-based fees for distribution services. Core business model spans over 40 years.
  2. Third-Party Logistics (3PL) Services: LogiCare3PL provides comprehensive third-party logistics including warehousing, cold chain distribution, inventory management, financial services, data analytics, licensing services, and regulatory compliance for specialty pharmaceutical manufacturers.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

BioCare product offering

Product offering

Core offering

BioCare is a specialty pharmaceutical distribution company that distributes life-saving therapies for rare, orphan, and ultra-rare diseases through its BioCareSD division. It also offers third-party logistics (LogiCare3PL), including warehousing, cold chain distribution, inventory management, order-to-cash services, financial services, data analytics, licensing, and regulatory compliance (DSCSA) for specialty pharmaceutical manufacturers.

Product overview

BioCare is a specialty pharmaceutical distribution company with a multi-brand platform consisting of BioCareSD (specialty distribution), LogiCare3PL (third-party logistics), and AllyGPO (group purchasing organization), along with supporting services QRCare (regulatory consultancy), CanyonCare Rx, and BioCareSD e-Commerce. The company serves manufacturers, pharmacies, healthcare providers, and patients across specialty drugs, rare diseases, oncology, and retina therapeutic areas.

Differentiator

Problem solved

Functional benefit

Products and services

  • BioCareSD Specialty Distribution Specialty pharmaceutical distribution division providing warehousing, fulfillment, and distribution of life-saving therapies (oncology, retina, rare/ultra-rare disease, plasma-derived, gene therapies, biologics) to specialty pharmacies, infusion centers, hospitals, and other sites of care. For pharmaceutical manufacturers and healthcare providers.
  • LogiCare3PL Third-Party Logistics Third-party logistics division providing warehousing, cold chain distribution, inventory management, financial services, data analytics, licensing services, and DSCSA regulatory compliance expertise and infrastructure for specialty and rare disease manufacturers.
  • AllyGPO Group Purchasing Organization Next-generation specialty group purchasing organization providing independent oncology and retina practices with purchasing power and optimized specialty drug distribution through strategic partnerships.
  • QRCare Regulatory Consultancy Quality and regulatory consultancy service providing strategic support for partners to develop and maintain quality and regulatory compliance programs in the pharmaceutical industry.
  • CanyonCare Rx Specialty Pharmacy Specialty pharmacy services division dispensing specialty medications to patients, particularly those with rare and complex diseases.
  • BioCareSD e-Commerce Platform Online ordering platform for BioCareSD customers to place orders and manage accounts electronically.

Quantifiable outcome

  • Recognized as Inc. 5000 Fastest-Growing Private Companies in America for two consecutive years (2022-2023)
  • +2 more outcomes

Companies that use BioCare

Customer profile

Named customers6 records

Segments5 records

Ideal customer profiles3 records

BioCare technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature3 records

BioCare partnerships and signals

Strategic signal

Partnerships

18 partnerships are on record, tiered core, flagship and strategic.

  • Oklahoma Cancer Specialists and Research Institute (OCSRI)coreChannel Partner/ Reseller/ Distributor · 18 June 2026OCSRI selected BioCareSD and AllyGPO as its primary specialty drug distributor and GPO partner.
  • AllyGPOflagshipStrategic or Co-development Partner · 9 June 2026Mission-aligned partnership with AllyGPO (next-generation specialty group purchasing organization) to transform specialty drug group purchasing and distribution for independent oncology and retina practices. Earned Gold Globee Award in 2026 for this partnership.
  • Utah Cancer SpecialistscoreChannel Partner/ Reseller/ Distributor · 27 May 2026Partnership with AllyGPO and BioCareSD to optimize specialty drug purchasing, distribution and drug management.
  • WeInfusestrategicTechnology or Integration · 19 May 2026Strategic partnership with WeInfuse, a leading infusion management technology platform used by providers across more than 1,300 locations nationwide. The collaboration enables closer integration for infusion practice technology capabilities.
  • Dothan Hematology & OncologycoreChannel Partner/ Reseller/ Distributor · 27 April 2026Selected AllyGPO and BioCareSD as primary specialty group purchasing and drug distributor partners.
  • Kedrion BiopharmacoreChannel Partner/ Reseller/ Distributor · 6 March 2026BioCare serves as a distribution partner for Kedrion's FDA-approved QIVIGY (intravenous immunoglobulin therapy). QIVIGY is Kedrion's first fully proprietary IVIG product, developed and manufactured through their integrated global network.
  • CuraScript SDcoreChannel Partner/ Reseller/ Distributor · 6 March 2026Distribution partner for Kedrion's QIVIGY product launch in the nationwide distribution network.
  • CencoracoreChannel Partner/ Reseller/ Distributor · 6 March 2026Distribution partner for Kedrion's QIVIGY product launch in the nationwide distribution network.
  • Cardinal HealthcoreChannel Partner/ Reseller/ Distributor · 6 March 2026Distribution partner for Kedrion's QIVIGY product launch in the nationwide distribution network.
  • McKesson Plasma and BiologicscoreChannel Partner/ Reseller/ Distributor · 6 March 2026Distribution partner for Kedrion's QIVIGY product launch in the nationwide distribution network.
  • PremiercoreChannel Partner/ Reseller/ Distributor · 6 March 2026Group purchasing organization (GPO) relationship supporting Kedrion's QIVIGY distribution through the nationwide network.
  • ChiRhoClin, Inc.coreChannel Partner/ Reseller/ Distributor · 16 July 2025LogiCare3PL serves as exclusive third-party logistics provider for ChiRhoStim (Human Secretin for injection), a product for pancreatic and gastrointestinal diagnostics.
  • Soleno TherapeuticscoreChannel Partner/ Reseller/ Distributor · 28 April 2025LogiCare3PL supported commercial launch of VYKAT XR (Soleno Therapeutics' FDA-approved therapy) for hyperphagia in Prader-Willi syndrome patients.
  • AeroSafe GlobalstrategicTechnology or Integration · 2 October 2024Partnership to launch sustainable cold chain solutions using innovative reusable temperature-controlled shipping containers for specialty pharmaceutical products.
  • GCBioPharmacoreChannel Partner/ Reseller/ Distributor · 19 August 2024Limited distribution partnership for ALYGLO (immune globulin intravenous, human-stwk), a 10% immune globulin liquid product.
  • HarrowcoreChannel Partner/ Reseller/ Distributor · 14 April 2024LogiCare3PL selected as distribution partner for Harrow's portfolio of ophthalmic disease management solutions, providing both non-title and 3PL title services.
  • AllyRetina GPOstrategicChannel Partner/ Reseller/ Distributor · 28 July 2023Launched specialty-only distributor-GPO alternative for community retina practices at the ASRS Annual Meeting, combining BioCareSD distribution with AllyRetina GPO services.
  • TraceLinkcoreTechnology or IntegrationPartnership with TraceLink to provide electronic portal solution for prescription drug pedigree compliance under DSCSA (Drug Supply Chain Security Act), allowing customers to view and download transaction history.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

BioCare competitors and assessment

Company assessment

Direct peers

  • FFF Enterprises: Specialty biopharmaceutical distributor serving plasma products, vaccines, and specialty therapeutics through VeriCap and NuFACTOR subsidiaries. Highly comparable as an independent specialty-only distributor focused on plasma/biologics distribution with cold chain capabilities.
  • CuraScript SD: Specialty pharmaceutical distributor focused on limited distribution for rare, orphan, and oncology therapies. Explicitly listed alongside BioCare as a distribution partner for Kedrion's QIVIGY launch, making it a direct competitor for the same manufacturer and provider accounts.
  • Specialty Networks: Specialty GPO and services platform serving community urology, oncology, and other independent specialty practices. Direct comparable to AllyGPO in providing GPO + distributor solutions for independent specialty practices.
  • Sharp Specialty (formerly BDI Pharma): Specialty distributor of plasma derivatives, vaccines, and specialty injectables. Comparable as an independent specialty-only distributor competing for the same plasma-derived and rare-disease manufacturer partnerships.

Emerging players

  • PCI Pharma Services: Global contract development and manufacturing organization with integrated specialty distribution and cold chain capabilities. Comparable as a competitor for specialty manufacturer 3PL mandates, though broader in scope including manufacturing services.

Broad incumbents

  • Cardinal Health Specialty Solutions: Specialty distribution business of Cardinal Health offering nuclear pharmacy, biopharma services, and provider solutions. Competes with BioCare for manufacturer distribution rights and community oncology/retina customers, with materially larger national scale.
  • Optum Specialty Pharmacy (Optum Rx): Specialty pharmacy and distribution arm of UnitedHealth/Optum. Competes with BioCare's CanyonCare Rx and for limited distribution rights on behalf of manufacturers seeking payer-integrated specialty channels.
  • Walgreens Specialty Pharmacy: Specialty pharmacy and distribution business with broad national reach. Competes for both distribution-to-pharmacy volumes and downstream specialty pharmacy fulfillment for the same oncology and rare-disease therapeutics BioCare distributes.
  • Cencora (AmerisourceBergen) / ASD Healthcare: Specialty and biologics distribution under ASD Healthcare and Specialty Provider Services. Cencora is explicitly a partner alongside BioCare on the QIVIGY launch, making it the most dominant competing specialty distributor for manufacturer mandates.
  • McKesson Specialty Health (Ontada): Specialty distribution and provider services arm of McKesson serving oncology practices and biologics manufacturers. Direct overlap with BioCare's oncology and retina segments; competes for the same limited distribution contracts and Prime Vendor Agreements.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

BioCare social profiles

Digital presence

BioCare compliance and trust

Trust signal

Compliance2 records

BioCare financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BioCare leadership team

Management profile

Number of profiles

Profiles9 records

BioCare subsidiaries and ownership

Company hierarchy

Subsidiaries5 records

BioCare funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BioCare M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioCare

What does BioCare do?

BioCare is a specialty pharmaceutical distribution company that distributes life-saving therapies for rare, orphan, and ultra-rare diseases through its BioCareSD division. It also offers third-party logistics (LogiCare3PL), including warehousing, cold chain distribution, inventory management, order-to-cash services, financial services, data analytics, licensing, and regulatory compliance (DSCSA) for specialty pharmaceutical manufacturers.

Is BioCare a public or private company?

BioCare is a private company. It is classified as venture growth investor backed and is currently operating.

When was BioCare founded?

BioCare was founded in 1981. It employs 101 to 250 people.

Where is BioCare based?

BioCare is headquartered in Tempe, Australia, in the Oceania region.

How does BioCare make money?

Two revenue lines are on record. Specialty Pharmaceutical Distribution is the primary driver. The others are third-Party Logistics (3PL) Services.

Who are BioCare's main competitors?

Direct peers on record are FFF Enterprises, CuraScript SD, Specialty Networks and Sharp Specialty (formerly BDI Pharma). PCI Pharma Services is listed as an emerging player. Broad incumbents are Cardinal Health Specialty Solutions, Optum Specialty Pharmacy (Optum Rx), Walgreens Specialty Pharmacy, Cencora (AmerisourceBergen) / ASD Healthcare and McKesson Specialty Health (Ontada).

Does BioCare have an API?

No public API is recorded for BioCare.

What industry is BioCare in?

BioCare's product category is Specialty Pharmaceutical Distribution. Its primary akta.pro industry code is CRAOAHAD, Specialty Pharmacy & Biologics Distribution, with a secondary code of HLAIAJAH, Biologics & Biosimilars Distributors. Its NAICS code is 42345 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
citybizBioCare Earns Fourth Consecutive Inc. 5000 Recognition as Innovative Specialty Distribution Model Gains MomentumBioCare has been named to the 2026 Inc. 5000 list, recognizing it as one of the fastest-growing private companies in America. The company ranked No. 2520, climbing 1,145 spots from its previous year's ranking, reflecting a 129% growth in revenue from 2023 to 2025. This marks the fourth consecutive year BioCare has made the list, underlining its successful strategy in the specialty pharmaceutical distribution sector.AijournBioCare Earns Fourth Consecutive Inc. 5000 Recognition as New Model for Independent Specialty Drug Distribution Gains MomentumBioCare has been named to the 2026 Inc. 5000 list for the fourth consecutive year, ranking No. 2520 based on 129% revenue growth from 2023 to 2025. The recognition highlights the company's expansion in specialty pharmaceutical distribution and strategic partnerships with entities like AllyGPO.PR NewswireKedrion Activates Nationwide Distribution Network for QIVIGY® in the U.S.Kedrion Biopharma announced the nationwide commercial availability of QIVIGY, its FDA-approved 10% Intravenous Immunoglobulin therapy, through a broad U.S. distribution network including specialty distributors CuraScript SD, Cencora, Cardinal Health, McKesson Plasma and Biologics, and BioCare, along with GPO partners Premier and Premier Innovatix. Approved by the FDA in late 2025, QIVIGY is Kedrion's first fully proprietary IVIG therapy, developed and manufactured through the company's integrated global network. The launch reflects more than a decade of scientific research and manufacturing investment, positioning Kedrion as a fully integrated biopharmaceutical company in the U.S. immunoglobulin market.BioSpaceKedrion Activates Nationwide Distribution Network for QIVIGY® in the U.S.Kedrion Biopharma announced the nationwide commercial availability of QIVIGY, its FDA-approved 10% intravenous immunoglobulin (IVIG) therapy, through a broad U.S. distribution network serving specialty pharmacies, infusion centers, hospitals, and other sites of care. Approved by the FDA in late 2025, QIVIGY is Kedrion's first fully proprietary IVIG product, developed and manufactured through the company's integrated global network, with distribution supported by key partners including CuraScript SD, Cencora, Cardinal Health, McKesson Plasma and Biologics, and BioCare, as well as GPO relationships with Premier. The launch represents a defining moment for the company, expanding access to high-quality plasma-derived therapies while reinforcing Kedrion's position as a fully integrated biopharmaceutical company.PR NewswireBIOCARE, INC. APPOINTS NEW CHIEF EXECUTIVE OFFICER & CHIEF OPERATING OFFICER TO EXECUTIVE LEADERSHIP TEAMBioCare announced the appointment of James Frary as Chief Executive Officer and Michael Kody as Chief Operating Officer, effective immediately, with Linda Matthews retiring after serving as CEO for over 25 years. Frary previously served as Chairman of BioCare's Board of Directors since 2022 and brings over two decades of healthcare industry experience, most recently as CEO of US Acute Care Solutions. The leadership transition positions BioCare to continue advancing its specialty pharmaceutical distribution model under its existing strategic direction.PR NewswireBioCare Named to Inc.'s Second Annual Power Partner AwardsBioCare was named to Inc.'s second annual Power Partner Awards, recognizing 389 B2B firms that support startups. The company, a specialty pharmaceutical distribution partner, delivers therapies for rare diseases and blood disorders. The award highlights its commitment to quality service and customer trust.PR NewswireBIOCARE NAMES TWO HEALTHCARE INDUSTRY VETERANS TO LEADERSHIP POSITIONSBioCare, Inc. has appointed two healthcare industry veterans to leadership positions: Mike Collins as Vice President of Sales for BioCareSD and Kevin Kissling as Vice President & General Manager of 3PL Services leading LogiCare3PL. Collins brings 25 years of healthcare industry experience, having previously held leadership roles at companies including Xeris Pharmaceuticals, BioMatrix Specialty Pharmacy, Baxalta, and Baxter Healthcare Corporation, most recently serving as an independent consultant for BioCareSD. Kissling previously launched and grew McKesson's 3PL business to over $1 billion in five years and will now oversee BioCare's third-party logistics operations.PR NewswireBioCare, Inc. Named to 2022 Inc. 5000 List of Fastest-Growing Private CompaniesBioCare, Inc., a specialty pharmaceutical distribution company based in Arizona, was named to the Inc. 5000 list of fastest-growing private companies in America, ranking No. 4740 as a first-time honoree. The company achieved this recognition through impressive revenue growth, launching a new quality and regulatory consultancy service, and expanding its leadership team amid broader economic challenges. Inc. magazine, which publishes the annual ranking, noted that the 2022 honorees collectively added more than 68,394 jobs over the past three years.PR NewswireBioCare, Inc. Appoints Tom Hart as Chief Operating Officer and Shane Arledge as Vice President of Financial Planning and AnalysisBioCare, Inc. announced the appointment of Tom Hart as Chief Operating Officer and Shane Arledge as Vice President of Financial Planning and Analysis to expand its leadership team. Hart brings nearly two decades of operational experience, including prior roles at McKesson and as COO of Benco Dental, while Arledge previously served as senior vice president and corporate controller at Associa. The CEO stated the new hires will help accelerate growth and improve customer service as the specialty pharmaceutical distribution company continues to expand.PR NewswireBioCare, Inc. Welcomes Cory Shouse as Senior Vice President of Information TechnologyBioCare, Inc., a specialty pharmaceutical distribution company headquartered in Tempe, Arizona, announced the appointment of Cory Shouse as Senior Vice President of Information Technology. Shouse brings over 15 years of pharmaceutical services and distribution experience, having previously held leadership roles at Tenet Healthcare and AmerisourceBergen. He will focus on delivering new digital capabilities, improving data and analytics, and enhancing customer experiences across BioCare's specialty distribution, pharmacy, and logistics operations.